The AIRQ effectively identifies asthma exacerbation risk at 3 months and 12 months among patients with varying levels of asthma severity.

A new Senate report found that drug companies involved in price deals with Trump have continued to raise prices on hundreds of medications.

President Trump signed an executive order boosting federal research into psychedelic substances and expanding their use in controlled treatment settings.

Patients newly diagnosed with IPF at the time of a respiratory-related hospitalization had significantly shorter survival.

Researchers reported favorable safety and tolerability for CS1 after 12 months of treatment in patients with pulmonary arterial hypertension.

After months of leadership changes, President Donald Trump has chosen a new candidate, Dr Erica Schwartz, to lead the CDC.

The FDA will soon review whether certain peptides should be allowed in customized medications made by compounding pharmacies.

Hydrogen sulfide can effectively reverse established hypoxia-induced PH and remodeling of pulmonary vascular structure in a rat model.

A newly developed DNAm-IgE score using 107 CpGs may identify early epigenetic patterns linked to childhood respiratory morbidity.

Efforts to crack down on illegal e-cigs in the US may not be keeping pace with sales, a new government report suggests.

The fatigue and breathlessness program specific to interstitial lung disease is feasible, acceptable, and clinically effective.

A lower stroke volume index was associated with higher risk of cardiac death and lung transplantation in children with ...